Ubiquity Genomics provides tools for targeted DNA sequencing.  The company’s proprietary technology allows researchers to focus genetic and epigenetic analyses on specific regions of the genome at a fraction of the cost of other commercially available approaches.  Release of MHC Complete, the company’s first product, is anticipated in the first quarter of 2014. MHC Complete reagents will enable scientists to sequence the entire MHC locus, a region of great importance to disease research.

Navigation

Color Skin